NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, UK.
Heart. 2013 Apr;99(7):474-9. doi: 10.1136/heartjnl-2012-303205. Epub 2013 Feb 2.
To investigate whether treatment of lesions of greater complexity is now undertaken and to assess the rates of procedural success per class of lesion complexity.
Observational study.
Despite impressive progress in treatment strategies and equipment, the success rate of percutaneous coronary intervention for chronic total occlusion (CTO) has remained relatively stable.
483 patients consecutively treated with CTO from 2003 to 2012.
The Multicenter CTO Registry of Japan (J-CTO) score was used to classify lesion complexity. The study population was subdivided into an early (period 1, n=288) and a late (period 2, n=195) period according to the routine implementation of novel techniques and advanced equipment.
Period 2 was marked by more 'difficult' and 'very difficult' lesions (J-CTO grades 2 and 3) being attempted, with procedural success increasing from 68.4% to 88.1% (p<0.001) and from 42.0% to 78.9% (p<0.001), respectively. 'Easy' and 'intermediate' lesions (J-CTO grades 0 and 1) were less common, but with similarly high success rates (89.1% vs 96.6% (p=0.45) for easy, and 86.3% vs 86.1% (p=0.99) for intermediate). Period 2 was characterised by a trend for more successful procedures overall (by 6.1%, p=0.09). Procedural complications were similarly low in both periods. J-CTO score and technical era were identified as independent correlates of success in the total population by logistic regression analysis.
Advanced CTO techniques and equipment have resulted in an increase in the successful treatment of highly complex lesions. Total success rate did not substantially improve, as it was counterbalanced by the increased rate at which complex lesions were attempted.
研究现在是否对更复杂病变进行治疗,并评估每类病变复杂性的程序成功率。
观察性研究。
尽管在治疗策略和设备方面取得了令人瞩目的进展,但经皮冠状动脉介入治疗慢性完全闭塞(CTO)的成功率仍相对稳定。
2003 年至 2012 年连续接受 CTO 治疗的 483 例患者。
采用日本多中心 CTO 登记处(J-CTO)评分对病变复杂性进行分类。根据新方法和先进设备的常规应用,将研究人群分为早期(第 1 期,n=288)和晚期(第 2 期,n=195)。
第 2 期尝试了更多“困难”和“非常困难”的病变(J-CTO 分级 2 和 3),程序成功率从 68.4%增加到 88.1%(p<0.001),从 42.0%增加到 78.9%(p<0.001)。“容易”和“中等”病变(J-CTO 分级 0 和 1)较少见,但成功率同样较高(容易病变为 89.1%比 96.6%(p=0.45);中等病变为 86.3%比 86.1%(p=0.99))。第 2 期总体上以 6.1%的趋势表现出更成功的手术(p=0.09)。两个时期的程序并发症相似。Logistic 回归分析确定 J-CTO 评分和技术时代是总人群成功的独立相关因素。
先进的 CTO 技术和设备导致高度复杂病变的成功治疗增加。总成功率没有显著提高,因为尝试复杂病变的比率增加抵消了这一提高。